PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

43,878 stories, page 573 of 732

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Price to earnings forward of Kobayashi Pharmaceutical Co., Ltd. – TRADEGATE:KOY

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Minister mulls establishing national network to collect expired medicines, prevent recirculation

Egypt TodayOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US Food and Drug Administration rejects petition to set Pfas limits in food

The GuardianOriginal source
🇪🇸Industryrovi.esTier 1 · Company source

ROVI y la Junta de Castilla La Mancha impulsan un marco de colaboración para modernizar servicios sanitarios mediante innovación tecnológica

Laboratorios RoviOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Letter to the chair of the Food Standards Agency

The Parliamentary Under-Secretary of State writes to the chair of the Food Standards Agency to confi...

UK Department of Health and Social CareOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Food Standards Agency (FSA) economic growth goals

Goals agreed with the Food Standards Agency to clarify how their actions should support economic gro...

UK Department of Health and Social CareOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

FSA, MHRA and NICE economic growth goals

Goals agreed between the Department of Health and Social Care and 3 organisations to clarify how the...

UK Department of Health and Social CareOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

National Institute for Health and Care Excellence (NICE) economic growth goals

Goals agreed with the National Institute for Health and Care Excellence to clarify how their actions...

UK Department of Health and Social CareOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Medicines and Healthcare products Regulatory Agency (MHRA) economic growth goals

Goals agreed with the Medicines and Healthcare products Regulatory Agency to clarify how their actio...

UK Department of Health and Social CareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

OKYO Pharma Reports Positive Feedback from FDA Type D

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA feedback pushes OKYO Pharma into Phase 3 eye-pain study

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Keenova's XIAFLEX met Phase 3 goals in foot disorder trial

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Former Merck and NASA Leaders Bring Strategic Expertise to SpaceMD Amid Rising Demand for its In-Space Pharmaceutical Development Capabilities

Business WireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Keenova Announces Positive Phase 3 Results in Clinical Trial of XIAFLEX® (collagenase clostridium histolyticum) for Treating Plantar Fibromatosis

PR NewswireOriginal source
🌍Industryir.biolinerx.comTier 1 · Company source

BioLineRx and Hemispherian Announce New Preclinical Data Demonstrating Strong Synergistic Effect between GLIX1 and PARP Inhibitor in a Patient-Derived Ovarian Cancer Xenograft Model

BioLineRxOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AstraZeneca secures ex-China license for Sino Biopharmaceutical’s experimental COPD drug

The Mighty 790 KFGOOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ultragenyx Pharmaceutical (RARE) Is Up 7.4% After Index Migration To Russell 2000 And Value Benchmarks - Has The Bull Case Changed?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ultragenyx Pharmaceutical (RARE) Is Up 7.4% After Index Migration To Russell 2000 And Value Benchmarks - Has The Bull Case Changed?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Saol Therapeutics Resubmits the New Drug Application for SL1009 (DCA) for the Treatment of Pyruvate Dehydrogenase Complex Deficiency (PDCD), an Ultra-Rare Disease

StreetInsiderOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Opus Genetics reaches FDA alignment on phase 3 registrational design for OPGx-LCA5 gene therapy

Ophthalmology Times EuropeOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Meningococcal reference unit request form

For submitting clinical samples to the meningococcal reference unit (MRU).

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG)

StockStoryOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Meningococcal reference unit (MRU): user manual

List of available tests for meningococcal disease, what specimens to send and turnaround times.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US biotech firm raises multi-million series B to scale astaxanthin production

Undercurrent NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

India renews push for pharma market access in China

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBITDA forward of Timing Pharmaceutical Co. Ltd. – TPEX:6659

TradingViewOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

New Hospital Programme annual report: financial year 2025 to 2026

An annual update on the government's New Hospital Programme, a major infrastructure initiative to tr...

UK Department of Health and Social CareOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

COVER vaccine coverage statistics: data submission and publication dates

Data submission deadlines and publication dates for the COVER programme.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Three biotech tenants move into former athenahealth HQ

The Business JournalsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is BioMarin Pharmaceutical (BMRN) Still Below Fair Value After Its Russell Index Additions?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ABL Bio advances ABL111 to Phase 3 in first-line gastric cancer, paving the way for 4-1BB platform licensing-out

더바이오Original source
🌍discoverynews.google.comTier 3 · Aggregated media

OKYO Pharma reports FDA feedback, advances urcosimod into Phase 3 trial for neuropathic corneal pain

Proactive financial newsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Helix opens genomic cohorts to AstraZeneca

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to EBIT forward of Hunan Er-Kang Pharmaceutical Co., Ltd. Class A – SZSE:300267

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enterprise value to revenue forward of Kobayashi Pharmaceutical Co., Ltd. – TSE:4967

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Suven Life Sciences Allocates 1.85 Crore Shares At ₹134 To Raise ₹248.84 Crore

SahiOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Serum Institute’s dengue drug to undergo global trials early next year

Indian Pharma PostOriginal source
🇮🇹Researchhumanitas-research.comTier 3 · Secondary coverage

A new culture system extends the viability of human liver slices and improves drug toxicity studies

Humanitas Research Hospital (Milan)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

LigaChem's ADC platform gains clinical traction through global partners

koreabiomed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

LigaChem Biosciences pivots to late-stage ADC 2.0, invests 1 trillion won - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA suspends Heera Sweets’ FSSAI licence

thehitavada.comOriginal source
🇫🇷Researchchu-lille.frTier 2 · Direct publisher

Almanach BPI 2008-2025

CHU LilleOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New Cancer Drug Vepdegestrant Gets FDA Approval

GK TodayOriginal source
🌍Industrymeridianbioscience.comTier 1 · Company source

Meridian Bioscience Announces Health Canada License for Alethia® CMV Assay

Meridian BioscienceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

UMB Celebrates America at 250: How the School of Pharmacy Helped Modernize the Drug Approval Process

The University of Maryland, BaltimoreOriginal source
🇩🇰Researchhealthsciences.ku.dkTier 2 · Direct publisher

After weight loss, exercise improves cardiovascular health more than weight-loss medication

University of Copenhagen - HealthOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Confirms Single Phase 3 Trial Sufficient for ATH434 NDA in MSA

The Clinical Trial VanguardOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

National flu and COVID-19 surveillance report, week 29 report: data to week 28 (data up to 12 July 2026)

National influenza and COVID-19 report, monitoring COVID-19 activity, seasonal flu and other seasona...

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech Double Winners Outperform the Market, With Fundamental Tailwinds Poised to Sustain Momentum

NAI500Original source
🌍discoverynews.google.comTier 3 · Aggregated media

S2G, Hatch-backed biotech raises millions, expands Corbion ties

intrafish.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Kintara (KINS) Price Prediction 2025–2026: Will It Rise?

BitgetOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

China’s biotech boom: RAS-targeted drugs challenge US dominance

South China Morning PostOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US FDA declines to approve Unicycive's kidney disease drug

MSNOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why is Sichuan Kelun Biotech stock sliding today?

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

D&D Pharmatech earns milestone as partner advances FAP PET imaging agent into phase 2

koreabiomed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

New weight loss pill beats oral Ozempic in major trial

ScienceDailyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

D&D Pharmatech earns milestone as partner advances FAP PET imaging agent into phase 2

koreabiomed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Woojung Bio changes name to Kolmar BioTech after joining Kolmar Group

koreabiomed.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

VKTX Vs BCRX: Which Biotech Takeover Favorite Offers More Upside After Vertex’s $10B CRNX Deal?

StocktwitsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

VKTX Vs BCRX: Which Biotech Takeover Favorite Offers More Upside After Vertex’s $10B CRNX Deal?

TradingViewOriginal source